|
Resolution: standard / high Figure 1.
The drug development sequence. Note that the drug sponsor accumulates large amounts
of data about the drug, and has eliminated the least promising agents before the design
process for randomized controlled trials occurs.
Fries and Krishnan Arthritis Res Ther 2004 6:R250 doi:10.1186/ar1170 |
